The Financial Express22h
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Unproven COPD treatments use doctored footage of Mehmet Oz, Snoop Dogg
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Expanded research on COPD and metabolic syndrome would advance patient-centered care, expert argues
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
News Medical on MSN10d
Addressing COPD and metabolic syndrome requires comprehensive research efforts
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
New Research: Smoking and Vaping Alters Key Lung Cells, Increasing Disease Risks
Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...
thecardiologyadvisor.com4d
In COPD, CV Events Increase With Use of Single-Inhaler Triple Therapy
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
GlobalData on MSN10d
AerWave Medical concludes study of ultrasound therapy for COPD
The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
EurekAlert!11d
Expanded research on COPD and metabolic syndrome would advance patient-centered care
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
News Medical on MSN13d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...